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ABSTRACT 24 
Background 25 
Enteric fever in France is primarily travel-associated. Characteristics of paediatric cases are 26 
scarce and information from field studies in endemic countries might not be generalizable to 27 
non-endemic countries. 28 
Methods 29 
In this retrospective study, we reviewed all cases of typhoid and paratyphoid fever treated in a 30 
French paediatric tertiary care centre from 1993 through 2015. 31 
Results 32 
Fifty cases of enteric fever due to Salmonella enterica serovar Typhi (n=44) and Paratyphi 33 
(n=6) were identified. Sixty-one percent of the children had travelled to Africa and 34 % to 34 
the Indian subcontinent. Among travel-associated cases, eighty-five percent were visiting 35 
friends and relatives (VFR). Ninety-six percent had high fever associated with gastrointestinal 36 
symptoms. Anaemia (66%), elevated CRP (80%), transaminitis (87%) and mild hyponatremia 37 
(50%) were the main biological findings. Blood cultures were positive in 90% of cases. 38 
Twelve strains (24%) were resistant at least to one antibiotic, and all of them had been 39 
isolated since 2003, increasing the resistance rate during this last period to 43% (12/28). 40 
Ceftriaxone was administered to 71 patients for a median duration of 6 days (IQR: 4‒8). The 41 
median time to apyrexia after onset of treatment was 4 days (IQR: 2‒5 days). Complications 42 
occurred in 9 children with 5 (10%) presenting neurologic disorders. All 50 patients 43 
recovered.  44 
Conclusion 45 
In France, paediatric enteric fever is mainly a travel-associated disease and occurs in patients 46 
returning from a prolonged stay in an endemic area. Children VFR are at high risk and should 47 
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be a priority target group for pre-travel preventive measures. The increase in antibiotic 48 
resistance reflects the situation in endemic countries and is a major concern. 49 
 50 
INTRODUCTION 51 
Typhoid and paratyphoid fever are systemic infections caused by human-adapted pathogens: 52 
Salmonella enterica, including S. enterica serovar Typhi (S. Typhi) and serovar Paratyphi (S. 53 
Paratyphi) A, B and C. These infections remain a major public health challenge in developing 54 
countries where populations live under conditions of poor sanitation. Over 26 million cases 55 
and 200,000 deaths are annually estimated worldwide, with the highest incidence being 56 
reported in Asia (over 100 cases per 100,000 persons/year) 
1,2
 and the greatest burden among 57 
children aged 2-15 years.
3,4
 In past decades, antimicrobial resistance sequentially emerged 58 
from resistance to first-line drugs (chloramphenicol, ampicillin and cotrimoxazole), to 59 
fluoroquinolone and very recently to cephalosporin, leading to treatment failures and 60 
therefore increasing the disease burden in endemic countries.
5,6
 61 
In developed countries, the incidence of enteric fever has dramatically declined over the past 62 
century and has become a predominantly travel-associated disease.
7
 In France, laboratory-63 
confirmed S. Typhi and S. Paratyphi infections are notifiable conditions and epidemiological 64 
investigations are carried out by Public Health authorities to prevent secondary transmission 65 
from identified cases and identify the source of contamination for non-travel-associated 66 
cases.
8
  ro       ‒2015, a total of 1928 cases were reported among residents of mainland 67 
France (mean estimated incidence: 1.84 cases per million population).
9
 Of those, 1577 (82%) 68 
occurred among travellers returning from endemic countries in the month prior to symptom 69 
onset, predominantly from Africa (48%), followed by Asia (46%). The risk for infection 70 
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among travellers varies with the destination and the purpose of travel.
7,8
 Travellers “visiting 71 
friends and relatives” (V R) are recognized as a high-risk group for enteric fever.10  72 
Current knowledge on paediatric enteric fever is mainly provided by studies in endemic 73 
countries where children bear the highest burden in terms of incidence and complications.
3,11
 74 
Clinical features of enteric fever might differ between younger and older children and adults.
4
 75 
In France, children under 18 years account for 32% of the total number of enteric fever cases.
9
 76 
Data describing paediatric enteric fever cases in non-endemic countries are scarce. 77 
Meanwhile, the proportion of children among travellers is increasing
12,13
 and particularly 78 
among VFR travellers where infants and young children are over-represented as compared 79 
with non-VFR travellers.
14,15
 Furthermore, compared with adult travellers, children are at 80 
higher risk for infectious diseases and specifically for faecal-oral infections.
16,17
 81 
To identify demographic, clinical and microbiological features of paediatric enteric fever in a 82 
non-endemic area, we conducted a retrospective analysis of all cases of typhoid and 83 
paratyphoid fever among paediatric patients in a French tertiary health care centre.  84 
PATIENTS AND METHODS 85 
Study design and definitions 86 
All cases of typhoid and paratyphoid fever among patients less than 18 years of age treated at 87 
the Robert-Debré teaching hospital in Paris, France, from July 1
st
 1993 through December 31
st
 88 
2015 were retrospectively reviewed. Robert-Debré Hospital serves a population with low 89 
socio-economic status and a large proportion of immigrants.
18
 90 
A case was defined, in accordance with the European and national case definition, as an 91 
“acute illness co patible with typhoid or paratyphoid fever (i.e sustained fever with 92 
headache, diarrhoea, constipation,  alaise or abdo inal pain…) associated with the isolation 93 
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of S. Typhi or S. Paratyphi A, B or C fro  blood, stool or other clinical speci ens” 1. Enteric 94 
fever was considered to be travel-associated if the patient had travelled within one month 95 
before symptoms onset, if not, cases were considered to be domestically-acquired.  96 
Data collection 97 
Cases were identified by querying both laboratory and hospital discharge databases using 98 
codes for S. Typhi, S. Paratyphi A, B and C and “typhoid and paratyphoid fever” according to 99 
the ICD-10. 100 
All epidemiological, demographic, clinical, biological, radiological, antimicrobial treatment 101 
and clinical outcomes data were extracted from medical charts and collected using EpiData 102 
Software® version 3.0 (The EpiData Association, Odense, Denmark). 103 
Laboratory methods 104 
Salmonella species and serovars were determined using biochemical tests (API 20
E 
system 105 
bioMérieux, Marcy-l’Etoile,  rance) and specific i  une sera. Susceptibility to anti icrobial 106 
drugs was tested by the disk diffusion method according to the French recommendations (CA-107 
SFM 20112); 32 antibiotics were tested. Minimum inhibitory concentrations (MIC) were 108 
determined using the E-test method (bioMerieux, Marcy-l’Etoile,  rance). We considered 109 
susceptibility to ampicillin, cotrimoxazole, ceftriaxone, nalidixic acid and ciprofloxacin; 110 
azithromycin was also considered for cases from 2009 and thereafter. Resistance to 111 
ceftriaxone was defined by a MIC above 2 mg/l. Resistance to nalidixic acid was defined by a 112 
MIC above 16 mg/l, decreased susceptibility to ciprofloxacin by a MIC between 0.5 mg/l and 113 
                                                            
1  2002/253/EC: Commission Decision of 19 March 2002 laying down case definitions for reporting 
communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament 
and of the Council. Official Journal, OJ L 86, 03.04.2002, p. 44–62 
2 http://www.sfm-microbiologie.org/UserFiles/files/casfm/casfm_2011.pdf 
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1 mg/l and resistance to ciprofloxacin by a MIC above 1 mg/l. A strain was considered 114 
susceptible to azithromycin if the MIC was below 16 mg/l. 115 
Statistical analysis 116 
Continuous variables were summarised using median and interquartile range (IQR), and 117 
categorical variables were summarised using frequencies and percentages. Continuous data 118 
were compared using the non-parametric Mann-Whitney test and rates using the Fisher exact 119 
test. Statistical significance was set at the 5% level (2-sided P value). Analyses were 120 
conducted using STATA software (version 11.0; StatCorp LP, College Station, TX, USA). 121 
Ethics approval 122 
Data collection was approved by the French National Data Protection Commission (number 123 
1898715) and the local institutional review board approved the study. Data were de-identified, 124 
in keeping with the French legislation 3. 125 
RESULTS 126 
Demographics and travel history 127 
From 1993 to 2015, 50 cases of typhoid (n=44) and paratyphoid (n=6) fever among children 128 
and adolescents were identified.  129 
Table 1 shows the general characteristics of the 50 patients included in the study. Median age 130 
was 7 years (IQR: 3.2‒10.8), and male-to-female ratio was 0.9. Patients were equally 131 
distributed among age groups.  132 
Forty-three patients (86%) had returned from an endemic region within 1 month prior to 133 
symptoms onset. Among the 41 travel-associated infections with available information 134 
                                                            
3 Loi n° 78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés modifiée. 
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regarding the region visited, 25 (61%) were acquired in Africa (Table 1). The reason for 135 
travel was known for 34 (81%) of these children: 29 (85%) were VFR and 3 (9%) were 136 
expatriates living in endemic countries. For the 39 returning travellers with complete 137 
information concerning dates of travel, the median duration of stay abroad was 8 weeks (IQR: 138 
5.6‒8.9).  139 
Seven children (14%) had no recent travel history. All those 7 non-travel-associated cases 140 
occurred over 10 years prior to our study; we were therefore not able to retrieve the results of 141 
the investigations conducted by the public health authorities since data had since been de-142 
identified. One patient had travelled to Cameroon 2 years prior to diagnosis and no 143 
microbiological investigations had been conducted within the family. Two patients had been 144 
in contact with a family member confirmed as a S. Typhi asymptomatic carrier. One case in 145 
1999 appeared to be linked to the ingestion of shellfish. For the 3 remaining cases, no 146 
information on the source of infection was available.  147 
Information concerning vaccinations was known for 45 (90%) patients. Three had received 148 
the Typhim Vi® vaccine within the past 3 years and all had travel-associated S. Typhi 149 
infections. For one, a S. Paratyphi A co-infection was additionally confirmed. 150 
Clinical findings 151 
Clinical findings are summarised in table 2. Of the 36 cases for which both date of return 152 
from travel and date of symptoms onset were available, median interval between return and 153 
symptoms was 0.5 days (IQR: -7‒13.5) and median interval from symptoms onset to 154 
diagnosis was 8 days (IQR: 4‒12). Illness was characterised by a history of fever combined 155 
with gastrointestinal symptoms in 48 patients (96%). Constipation (6%), rose spots (6%), 156 
splenomegaly (6%) and relative bradycardia (6%) were not commonly reported. 157 
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Clinical findings were not significantly different in patients infected with S. Typhi compared 158 
with the patients infected with S. Paratyphi and  (data not shown). 159 
Laboratory and imaging features 160 
The main laboratory findings are presented in table 2. Anaemia, according to the WHO 161 
definition4, was present in 33 (66%) patients with 10 (31%) presenting a mild and 21 (66%) a 162 
moderate anaemia. Among them, one patient with a pre-existing chronic renal failure 163 
presented with severe anaemia requiring red blood cell transfusion. Thirty-nine (87%) patients 164 
had elevated liver enzymes of which 14 (31%) had AST and/or ALT 3-fold above normal. Of 165 
these, 5 exhibited a clinical and radiological hepatomegaly and 3 had jaundice. Twenty-four 166 
(50%) patients presented with hyponatremia at time of diagnosis. In 10 (21%), sodium level 167 
was under 130 mmol/l and in 4 (8%) under 125 mmol/l.  Biologic features were not 168 
significantly different in patients infected with S. Typhi compared with patients infected with 169 
S. Paratyphi (data not shown). 170 
Abdominal ultra-sound was performed in 24 (48%) patients, 11 (46%) were considered 171 
normal, whereas 10 (42%) showed hepatomegaly, of which 3 were combined with a 172 
splenomegaly. Splenomegaly alone was found in 2 (8%) patients, and one had gall bladder 173 
stones. 174 
Microbiological findings   175 
Overall, 44 (88%) S. Typhi  and 6 (12%) S. Paratyphi, including 4 S. Paratyphi A and 2 S. 176 
Paratyphi B, strains were identified. Strains were isolated in blood culture (n=45; 90%), in 177 
stool culture (n=3; 6%) or in urine culture (n=2; 4%). 178 
                                                            
4 http://www.who.int/vmnis/indicators/haemoglobin.pdf 
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Thirty-five (80%) S. Typhi and 6 (100%) S. Paratyphi infections were travel-associated. All S. 179 
Paratyphi A strains were isolated in patients returning from the Indian sub-continent.  180 
Table 3 shows the antibiotic resistance profiles of the 12 non-fully susceptible strains, which 181 
have all been isolated since 2003. As such, since 2003, 43% (12/28) of the isolated strains 182 
showed antibiotic resistance. Eleven (79%) of the 14 strains isolated from patients returning 183 
from the Indian sub-continent and 1 (8%) of the 12 isolated from patients returning from Sub-184 
Saharan Africa were resistant. No strain was resistant to third-generation cephalosporin, and 185 
the azithromycin MIC was below 16 mg/L for all strains.  186 
Management and outcome 187 
Forty-eight patients (96%) were admitted to hospital for a median duration of 7 days (IQR: 188 
5.5‒9).  189 
A third-generation cephalosporin was administered as the first-line regimen to 47 (94%) 190 
patients, of which 46 (92%) received ceftriaxone for a median duration of 6 days (IQR: 4‒8) 191 
at a median dose of 50 mg/kg/d (IQR: 50‒75). Two patients received ciprofloxacin at 192 
admission, one for a urinary tract infection. Additional antibiotics were administered to 23 193 
(46%) children, of which 13 (57%) received an aminoglycoside. Two patients were not 194 
admitted and received daily IV ceftriaxone in the outpatient department. Six patients received 195 
azithromycin during 4 to 7 days after a short course (5 days) of ceftriaxone and 6 received 196 
ciprofloxacine during 5 to 7 days. 197 
The median time to apyrexia after onset of treatment was 4 days (IQR: 2‒5).  198 
Complications occurred in 9 (18%) patients, and 4 (8%) were admitted to a paediatric 199 
intensive care unit (PICU); 5 (10%) presented neurologic disorders such as confusion and 200 
altered consciousness. Encephalitis was diagnosed in one, who presented febrile seizures, 201 
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confusion and altered consciousness. He recovered after 48 hours of antibiotic treatment. One 202 
patient was admitted to PICU for severe dehydration. Appendicitis, syndrome of 203 
inappropriate antidiuretic hormone secretion and haemophagocytic syndrome were observed 204 
in 1 patient each. Five children had a follow-up visit with stool culture 2 weeks to one month 205 
after discharge. All 50 children fully recovered. 206 
DISCUSSION 207 
To our knowledge, this is the largest study of enteric fever among children in a European 208 
hospital. This study highlights the demographic, clinical and microbiologic characteristics of 209 
50 paediatric cases. Forty-three (86%) cases were imported, of which 61% were acquired in 210 
Africa. This distribution is different from what is reported in other studies from non-endemic 211 
countries where most infections were acquired in the Indian subcontinent and South-East 212 
Asia.
13,19,20
 It is however consistent with French national surveillance data fro      ‒2015 213 
which show that travel-associated enteric fever cases among persons aged under 18 are 214 
predominantly acquired in Africa (61%) followed by Asia (36%).
9
 Forty-four percent of 215 
immigrants in France come from Africa, 31% from Europe and 25% from the rest of the 216 
world. The proportion of immigrants originating from Africa is even higher in Paris region, 217 
with 50% versus 3.7% from the Indian subcontinent.
18
The observed distribution might reflect 218 
the countries of origin of the immigrant population served by the Robert Debré Hospital. 219 
Furthermore, this immigrant population includes a substantial proportion of VFRs 
21
 and 220 
children are over represented among VFR travellers as compared to non-VFR travellers.
10,14
  221 
 In this case series, 85% of the travelling children were VFRs. The median duration of stay in 222 
an endemic region was prolonged (8 weeks). Studies have identified that length of stay, visits 223 
to rural areas, not following food and water precautions and not receiving pre-travel advice 224 
are factors associated with a higher risk for enteric fever among travellers.
22
 VFR travellers 225 
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usually combine these risk factors
23
: in a study among returning travellers in Quebec, VFRs 226 
accounted for 94.4% of typhoid cases.
10
 Furthermore, the majority of the children in our study 227 
had not been vaccinated, which suggests a lack of pre-travel health advice. VFR travellers 228 
face multiple barriers to accessing and/or accepting pre-travel health advices including 229 
language barriers, lack of knowledge about travel-associated health risks, and a perception of 230 
an immunity due to previous travels stay and/or birth in their country of origin 
21
 Therefore, 231 
children VFR should be a priority target group for preventive pre-travel measures. Increasing 232 
the awareness of healthcare professionals on travel-associated risks in this group is one key 233 
element to reduce the number of imported cases of enteric fever.
10,21
 234 
In our study, seven (14%) cases were acquired domestically, all before 2001. Epidemiological 235 
investigations carried out by the Public Health authorities for non-travel-associated cases aim 236 
to (i) identify the source of infection and (ii) mitigate the risk for secondary transmission and 237 
outbreaks. These investigations are complex and resource intensive. They might require 238 
screening for chronic carriers, acute or convalescent patients or contaminated food and often 239 
the source is not identified. 
24
  240 
Three children above 2 years of age had a documented history of typhoid vaccination. Two 241 
types of vaccines are recommended for travellers: a live-attenuated oral vaccine (Ty21a) and 242 
a parenteral Vi polysaccharide vaccine. In France, only the typhoid Vi vaccine is available 243 
and recommended to travellers above 2 years of age.
25
 The effectiveness of both vaccines is 244 
moderate and ranges from 60% to 80% and appears to be similar among travellers as among 245 
population in endemic regions. 
26–28
 Conflicting results have been published in children from 246 
2 to 5 years old, effectiveness varying from 35% in Pakistan to 80% in India but was similar 247 
to adults in travellers from UK.
28
 Furthermore, these vaccines are effective only against S. 248 
Typhi strains, yet the incidence of S. Paratyphi A appears to be growing, exceeding the 249 
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incidence of S. Typhi in certain regions.
29
 These findings underline that hygiene precautions 250 
remain essential to prevent these water- and food-borne diseases.  251 
As described in previous studies among children and adults in endemic and non-endemic 252 
countries, clinical features of enteric fever are non-specific and mimic other febrile illnesses 253 
like malaria, dengue fever or influenza, especially in younger children.
4,19,20,30,31
 Fever 254 
(48‒96%), asthenia (42‒84%) and intestinal symptoms (e.g., diarrhoea (37‒74%), vomiting 255 
(24‒48%) and abdominal pain (25‒50%)), were the most common findings in our case series. 256 
More specific features (e.g., rose spots, relative bradycardia) appear in the third or fourth 257 
week of evolution, which is rarely observed in European medical settings.
32
 Mild anaemia 258 
elevated liver enzymes; raised CRP and mild hyponatremia were the main biological findings 259 
in our patients.. Over 80% of them exhibited elevated transaminases, and 31% had rates more 260 
than threefold above the normal range.. Typhoid hepatitis is more frequently seen in children
4
 261 
and distinguishing typhoid hepatitis from viral hepatitis can be challenging. Transaminitis is 262 
less acute and less severe in typhoid hepatitis than in other acute types of hepatitis, and the 263 
outcome is always favourable after antibiotic treatment.
33
 Hyponatremia, reported in 50% of 264 
our patients, was also described in the same proportion in two adult case series.
19,30
 Although 265 
the pathophysiology is unclear, one could suggest a syndrome of inappropriate antidiuretic 266 
hormone secretion or haemophagocytic syndrome.   267 
Apyrexia was obtained in 4 days (IQR: 2‒5) after onset of treatment, which is consistent with 268 
paediatric studies in endemic countries. Complications were reported in 9 (18%) children, of 269 
which 5 presented neurological disorders and 4 required a transfer to a PICU. These rates are 270 
higher than those reported in adult return travellers
20,30,31
 and closer to those observed among 271 
children in endemic countries.
4
 In endemic countries, neurologic complications are 272 
predominantly described in children whereas neuropsychiatric changes, delirium and 273 
insomnia are more frequent in adults.
4,34
  274 
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In this case series, since 2003, 43% of the isolated strains demonstrated resistance or reduced 275 
susceptibility to antibiotics, mostly imported from South Asia, with different resistance 276 
patterns reflecting the recent and rapid evolution of resistance mechanisms in this region.
5,6
 277 
As multidrug-resistant strains (resistant to chloramphenicol, cotrimoxazole and ampicillin) 278 
became widespread in the 1980s 
6,35
, fluoroquinolones have provided an effective simple oral 279 
regimen in the last two decades. However, the emergence of nalidixic acid-resistant strains 280 
with decreased susceptibility and documented resistance to ciprofloxacin 
36
 has been 281 
associated with prohibitive rates of treatment failure and relapse in endemic regions as well as 282 
among travellers. 
37–39
 These evolutions have been observed in South Asia and, in lower 283 
proportions, in Africa.
5,36,38
 Thus, a 10 to 14 days course of ceftriaxone appears to be a 284 
reasonable option as first-line treatment for adults returning from the Indian sub-continent and 285 
all paediatric patients
36,37
. Although relapse rates of 5 to 15% at 1 month have been described 286 
with short-course ceftriaxone therapy
40,41
, 94% of the patients in our series received a short-287 
course of ceftriaxone (median 6 days; IQR: 4‒8.5) and no relapse or treatment failure were 288 
observed. Meanwhile, as in non-Typhi Salmonella and Enterobacteriaceae, extended-289 
spectrum beta-lactamase (ESBL)-producing S. Typhi and S. Paratyphi A isolates have 290 
recently been reported. 
42
 291 
Trials suggest short-course azithromycin (20 mg/kg/day, with a maximum dose of 1000 292 
mg/day) as a safe therapeutic option for uncomplicated enteric fever in children and 293 
adults.
37,40,43
 The once-daily administration combined with the short duration of treatment 294 
could improve compliance and therefore ease the treatment of enteric fever 
37,43
 Although no 295 
clinical breakpoints are available to define azithromycin susceptibility or resistance, alarming 296 
reports of strains with increasing MICs for azithromycin have been published.
44
 297 
This descriptive analysis of 50 paediatric enteric fever cases highlights that paediatric 298 
enteric fever in France is mainly travel-associated and that children VFR are particularly at 299 
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risk. In returned travellers, high fever associated with intestinal and/or neurological 300 
symptoms, elevated CRP, mild hepatitis, hyponatremia and anaemia should alert physicians 301 
to the possibility of enteric fever, and blood cultures should be performed. The increase of 302 
antibiotic resistance of S. Typhi and S. Paratyphi isolates in travel-associated cases reflects the 303 
situation in endemic countries and is a major concern. Children VFRs bear the highest burden 304 
of infectious diseases, including enteric fever, and pre-travel health preventive programs 305 
should target this high-risk group of travellers.  306 
 307 
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No. (%)  
(n=50) 
Median age, years (IQR) 7 (3.2‒10.8) 
Sex  
Male 22 (44%) 
Female 28 (56%) 
Domestically-acquired infection 7 (14%) 
Travel history 43 (86%) 
   Reason for travel (n=34)  
VFR 29 (85%) 
Tourism 2 (6%) 
Othera 3 (9%) 
   Region visited  (n=41)  
Sub-saharan Africa 14 (34%) 
Indian Sub-continent 14 (34%) 
North Africa 11 (27%) 
Middle East 1 (2%) 
Otherb 1 (2%) 
Median duration of stay in an endemic region, weeks (IQR)c 8 (5.6-8.9) 
IQR: interquartile range; VFR: visiting friends and relatives 
a 3 patients were long-term expatriates returning from endemic countries 
b  French Guiana  
c For the 39 children who were not long-term expatriates returning from an endemic region 
 
Table 1. General characteristics and travel history of the 50 children with enteric 
fever 
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  No. (%)  
Symptoms   
Fever 48 (96 %) 
High grade fever (>40°C) 24 (48 %) 
Chills 24 (48 %) 
Asthenia 42 (84 %) 
Headache 14 (28 %) 
Abdominal pain 25 (50 %) 
Nausea 9 (18 %) 
Vomiting 24 (48 %) 
Diarrhea 37 (74 %) 
Blood in stools 2 (4 %) 
Constipation 3 (6 %) 
Physical signs  
Tachycardia 13 (26 %) 
Relative bradycardia 3 (6 %) 
Dehydration 22 (44 %) 
Jaundice 6 (12 %) 
Rose spots 3 (6 %) 
Abdominal tenderness 24 (48 %) 
Hepatomegaly 13 (26 %) 
Splenomegaly 3 (6 %) 
  
Laboratory features  
Anaemiaa  33 (66%) 
Leucopenia < 4000 / mm3 2 (4 %) 
Neutropenia < 1500/mm3 4 (11 %)b 
Thrombopenia <  150.000 /mm3 9 (18 %) 
CRP > 10 mg/L 40 (80 %) 
Elevated AST and/or ALT  > 45 UI/lc 39 (87%) 
AST and/or ALT > 3N 14 (31 %) 
Hyponatremia < 134 mmol/Ld 24 (50 %) 
a 
Acording to the WHO definition of anaemia adjusted to age 
(http://www.who.int/vmnis/indicators/haemoglobin pdf, accessed [17th july 2016]).  
b
 Out of 36; c out of 45; d out of 48  
Table 2. Clinical and biological features of the 50 children with enteric fever 
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  Year 
S. enterica 
Serovar Country 
Antibiotic resistance 
profile 
          
1 2003 Typhi Cameroun MDR 
2 2005 Typhi Pakistan NalR  
3 2006 Typhi Pakistan NalR  
4 2007 Typhi India Nal
R
  
5 2007 Typhi Bangladesh MDR-NalR 
6 2009 Typhi Pakistan MDR-NalR 
7 2009 Typhi Pakistan MDR-NalR 
8 2010 Typhi Bangladesh NalR  
9 2010 Paratyphi Bangladesh NalR  
10 2010 Paratyphi Pakistan CipR 
11 2013 Typhi Bangladesh MDR-NalR 
12 2015 Typhi India NalR  
MDR: Multiple drug resistance (resistant to the traditional first-line antimicrobial agents: ampicillin, 
chloramphenicol and cotrimoxazole) 
Nal R: resistant to Nalidixic acid (MIC>16 mg/l) and decreased ciprofloxacin susceptibility (MIC between 
0.125 and 1 mg/l) 
CipR: Resistant to ciprofloxacin (MIC >1 mg/l)   
Table 3. Antibiotic resistance profiles and geographical origin of the 12 resistant 
Salmonella enterica strains 
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